Resveratrol Reduces the Invasive Growth and Promotes the Acquisition of a Long-Lasting Differentiated Phenotype in Human Glioblastoma Cells-Reference-Cited by-同舟云学术

Resveratrol Reduces the Invasive Growth and Promotes the Acquisition of a Long-Lasting Differentiated Phenotype in Human Glioblastoma Cells

Published:2011-03-11 Issue:8 Volume:59 Page:4264-4272
ISSN:0021-8561
Container-title:Journal of Agricultural and Food Chemistry
language:en
Short-container-title:J. Agric. Food Chem.

Author:

Castino Roberta¹,Pucer Anja¹²,Veneroni Roberta¹,Morani Federica¹,Peracchio Claudia¹,Lah Tamara T.²,Isidoro Ciro¹

Affiliation:

1. Laboratorio di Patologia Molecolare, Dipartimento di Scienze Mediche, Università del Piemonte Orientale A. Avogadro, 28100 Novara, Italy

2. Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, and Faculty of Chemistry and Chemical Technology, University of Ljubljana, SI-1000 Ljubljana, Slovenia

Publisher

American Chemical Society (ACS)

Subject

General Agricultural and Biological Sciences,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/jf104917q

Reference42 articles.

1. Genetic alterations and signaling pathways in the evolution of gliomas

2. Higher pAkt Expression Predicts a Significant Worse Prognosis in Glioblastomas

3. DNA repair and cancer stem-like cells – Potential partners in glioma drug resistance?

4. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of Natural Products in the Treatment of Glioma: Focus on Molecular Mechanisms;Cell Biochemistry and Biophysics;2024-08-16

2. Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths;Acta Histochemica;2023-08

3. Cellular senescence in glioma;Journal of Neuro-Oncology;2023-07-17

4. Glioblastoma-on-a-chip construction and therapeutic applications;Frontiers in Oncology;2023-07-12

5. Resveratrol in Cancer Treatment with a Focus on Breast Cancer;Current Molecular Pharmacology;2023-06